Ceres will release new varieties of sorghum in 2014/15 harvest and commemorates obtained in 13/14 performance
Ceres is also a major technology provider to market leaders outside of dedicated energy crops.
Since 2002, we have leveraged our capabilities into traditional row crops, such as corn and soybean, through a multi-year, $137 million agreement with Monsanto.
The deal — the largest in the plant genomics industry — has been a key validation of our genomics and trait development capabilities. As part of this broad collaboration, Monsanto obtained a royalty-bearing license to a large number of lead genes for commercialization in selected row crops.
We continue to explore new commercial relationships to leverage our proprietary technology platforms with market leaders in areas outside of dedicated energy crops.
It appears that the stock has hit bottom. Been trending at this level for some time. Any good news will shoot up up up!
Software Sales and Marketing Manager 256738 US-CA-Thousand Oaks 09/04/2014
So this position was filled? Management must be realizing that they need to start producing net revenue!!! This is a great step in the right direction!
Patent application number Title Published
20140245474 NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS IN RESPONSE TO COLD - Methods and materials for modulating cold tolerance levels in plants are disclosed. For example, nucleic acids encoding cold tolerance-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased cold tolerance levels and plant products produced from plants having increased cold tolerance levels. 08-28-2014
20140096286 PROMOTER, PROMOTER CONTROL ELEMENTS, AND COMBINATIONS, AND USES THEREOF - The present document is directed to promoter sequences and promoter control elements, polynucleotide constructs comprising the promoters and control elements, and methods of identifying the promoters, control elements, or fragments thereof. The document further relates to the use of such promoters or promoter control elements to modulate transcript levels in plants, and plants containing such promoters or promoter control elements. 04-03-2014
20140058075 NUCLEIC ACID SEQUENCES ENCODING SecE/Sec61-GAMMA SUBUNITS OF PROTEIN TRANSLOCATION COMPLEXES - Isolated polynucleotides and polypeptides encoded thereby are described, together with the use of those products for making transgenic plants. 02-27-2014
20140046641 Materials and Methods for Use in Biomass Processing - Methods and materials for measuring the composition of plant biomass and predicting the efficiency of conversion of such biomass to various end products under various processing conditions are disclosed. For example, methods and materials for identifying plant material having higher levels of accessible carbohydrate, as well as materials and methods for processing plant material having higher levels of accessible carbohydrate are disclosed. Also disclosed are computer-implemented methods and systems that provide improved economic efficiencies to biorefin
Check out their website! They have a job posting for a sales position. About time they start focusing on generating sales and revenue!
Software Sales and Marketing Manager
Ceres is seeking an experienced software sales manager for our innovative denomics software platform, Persephone TM. The Sales Manager will report directly to the Vice President of Genomics Technologies and be responsible for both strategic planning and implementation of well-integrated sales and marketing plans for verious licensing options and services, including large-scale installations, Software as a Service (SaaS), and maintenance and support plans. The ideal candidate will have a proven history of selling technical solutions to scientists, bioinformaticians, IT professionals and senior managers/executives in the life sciences. The position is located in Thousand Oaks, California.
I received your inquiry about Persephone and would be happy to discuss the software with you if you would like.
The software today, is a client/server install which runs an Oracle back-end (so has been licensed to companies such as Bayer and Syngenta for their research needs).
Later this year (in a couple of months actually) we will be rolling out a SaaS model which will allow individual researchers to utilize the software without needing all the back-end infrastructure.
Please let me know if you want more information on the client/server model or if you would like to stay updated on the SaaS product (Persephone CloudService I believe the name is now).
VP, Genomic Technologies
Short lies-glad to see you are back. This board needed some amuzement. BTW the company in not in "bankruptcy"...not even close. You are going to get burned if you try to short at these prices.